Verastem | VSTM - Ativo Circulante





Ativo Circulante Alterar Data
AbbVie USD 29.06B 523M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
AstraZeneca USD 28.72B 1.22B 2025-12
Curis USD 6.92M 7.5M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Incyte USD 5.02B 746.01M 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
TG Therapeutics USD 630.76M 31M 2025-12
Verastem USD 223.41M 69.36M 2025-12